Stocks · Korea 450330 KOSDAQ

Hass

5,050원 +0.00% Market cap 413억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER26.03x
PBR0.89x
EPS194 KRW
BPS5,666 KRW
ROE3.31%
DPS60 KRW

Returns and 52-week range

1W+7.26%
1M+2.20%
3M-2.86%
6M-24.33%
1Y-29.95%
YTD-20.93%
52W high8,700원
52W low3,650원
From 52W high-41.38%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2024162억12억18억7.7%
2025166억9억15억5.4%
Quarterly
2024 3Q34억-2억-74,532,807원-5.4%
2025 1Q33억-7억-8억-20.9%
2025 2Q46억10억10억20.9%
2025 3Q48억3억3억6.3%
2025 4Q38억3억10억8.6%
2026 1Q33억-8억-9억-24.6%

Company

CEO김용수
Founded2008-01-04
Fiscal year end12
Address: 강원특별자치도 강릉시 과학단지로 77-14 하스 본사

Peers in the same sector

CompanyMarket capP/EP/B1M
원바이오젠425억6.420.99-2.92%
알리코제약362억—0.45-4.44%
명문제약446억23.070.45+5.20%
유틸렉스353억—2.31+0.00%
HLB펩474억—1.80+18.39%
고려제약353억5.330.42-8.29%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.